Vascular endothelial growth factor antagonist peptides inhibit tumor growth and metastasis in breast cancer through repression of c-src and STAT3 genes.
Maedeh BejariSoheila Talesh SasaniS Mohsen AsghariMozhgan Nabatzade KolshanPublished in: Molecular biology reports (2023)
In conclusion, peptides VGB1, 3, and 4, could be effective therapeutic molecules in breast cancer by inhibiting angiogenesis and progression of the disease.